Mission
To become the global leader in transformative protein diagnostic technology, enabling accessible, fast, and reliable disease detection.
About Us
AperionDx was founded on a single principle: protein testing should be fast, exquisitely sensitive, and easy to integrate and scale — addressing a market where competitive approaches remain costly and hardware-dependent.
Mission
To become the global leader in transformative protein diagnostic technology, enabling accessible, fast, and reliable disease detection.
Vision
To set a new benchmark in diagnostics through Protein-PCR™, delivering next-level sensitivity, specificity, and scalable access.
The Record
Core team members
Contributors over company history
Government funding secured
Years combined experience
Successful exits
Patents
Leadership
Chief Executive Officer
Chief Executive Officer
Holds a PhD in Biochemistry with 40+ years in biotech and medical diagnostics across major companies including DuPont, J&J, Boston Scientific and Abbott. Contributed to 2 Industrial Research Awards and commercialized 18 products, 12 of them FDA-cleared or approved.
Chief Scientific & Operating Officer
Chief Scientific & Operating Officer
PhD in Chemical Engineering with 16 years of senior experience at Wondfo USA, Thermo Fisher and others. Certified Black Belt in Quality Engineering; manages R&D, regulatory, manufacturing and quality operations.
VP, Sales and Marketing
VP, Sales and Marketing
B.S. in Biology with 30+ years driving corporate growth through acquisitions at BioMicro Systems, Empi, Sorenson Medical and Gesco.
Work with us
Need customized, ultra-sensitive diagnostic tests for specific protein biomarkers essential for drug or therapeutic development? Call AperionDx.